{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:04Z","timestamp":1791910384274,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017480","name":"Chang Bing Show Chwan Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118269","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:43:03Z","timestamp":1784331783000},"page":"118269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["The RAC1 tripartite hub: coupling metabolic plasticity and immune evasion to dictate breast cancer cell fate"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9035-5408","authenticated-orcid":false,"given":"Hung-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Heng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6916","key":"10.1016\/j.bcp.2026.118269_b0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0092-8674(95)90370-4","article-title":"Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia","volume":"81","author":"Nobes","year":"1995","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2026.118269_b0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0092-8674(92)90164-8","article-title":"The small GTP-binding protein rac regulates growth factor-induced membrane ruffling","volume":"70","author":"Ridley","year":"1992","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.bcp.2026.118269_b0020","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aea1212","article-title":"Tumor-derived RAC1(A159V) mutation promotes an immunosuppressive microenvironment that represses response to immune checkpoint inhibitor","volume":"11","author":"Cai","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-70683-x","article-title":"Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1\/Rac1 signalling","volume":"17","author":"Fernandez","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70165","article-title":"Mapping three decades of rho GTPase signalling in cancer: unveiling loopholes and future directions (1990-2024)","volume":"44","author":"Hasnizan","year":"2026","journal-title":"Cell Biochem. Funct."},{"issue":"9","key":"10.1016\/j.bcp.2026.118269_b0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41388-022-02574-6","article-title":"RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"issue":"888","key":"10.1016\/j.bcp.2026.118269_b0040","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adu3794","article-title":"YAP controls cell migration and invasion through a Rho GTPase switch","volume":"18","author":"Shah","year":"2025","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21541248.2025.2505977","article-title":"The role of RAC1 in resistance to targeted therapies in cancer","volume":"15","author":"Uribe-Alvarez","year":"2025","journal-title":"Small GTPases"},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/BST20250097","article-title":"Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities","volume":"54","author":"Beaudin","year":"2026","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bcp.2026.118269_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122510","article-title":"Implication of Rac1 GTPase in molecular and cellular mitochondrial functions","volume":"342","author":"Bailly","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118269_b0060","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7150\/ijms.104488","article-title":"Comprehensive pan-cancer analysis of RAC1 decoding the impact on cancer prognosis and b cell immune regulation","volume":"22","author":"Shao","year":"2025","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ddc5010017","article-title":"Cancer metabolism and its historical & molecular foundations: an overview","volume":"5","author":"Al-Horani","year":"2026","journal-title":"Drugs Drug Candidates"},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci Adv."},{"issue":"3","key":"10.1016\/j.bcp.2026.118269_b0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00037.2024","article-title":"Metabolic adaptations in cancer progression","volume":"106","author":"Peng-Winkler","year":"2026","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","article-title":"Cancer metabolism and carcinogenesis","volume":"13","author":"Yang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","article-title":"Mitochondrial metabolism and cancer therapeutic innovation","volume":"10","author":"Du","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.118269_b0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/0008-5472.CAN-11-2371","article-title":"Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells","volume":"72","author":"Doe","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118269_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102926","article-title":"Mitochondrial complex I ROS production and redox signaling in hypoxia","volume":"67","author":"Okoye","year":"2023","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118269_b0105","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ymthe.2025.10.049","article-title":"RAC1 directly phosphorylates both PKM2 and FBP1 to promote radioresistance in hepatocellular carcinoma","volume":"34","author":"Jiang","year":"2026","journal-title":"Mol. Ther."},{"issue":"7184","key":"10.1016\/j.bcp.2026.118269_b0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"issue":"7184","key":"10.1016\/j.bcp.2026.118269_b0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature06667","article-title":"Pyruvate kinase M2 is a phosphotyrosine-binding protein","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"issue":"7517","key":"10.1016\/j.bcp.2026.118269_b0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature13557","article-title":"Fructose-1,6-bisphosphatase opposes renal carcinoma progression","volume":"513","author":"Li","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0125","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41467-020-15308-7","article-title":"Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2026.118269_b0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci"},{"issue":"2","key":"10.1016\/j.bcp.2026.118269_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020610","article-title":"The pentose phosphate pathway: from mechanisms to implications for gastrointestinal cancers","volume":"26","author":"Qiao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118269_b0140","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/15548627.2025.2452149","article-title":"Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting","volume":"21","author":"Xu","year":"2025","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bcp.2026.118269_b0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.118269_b0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR Signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118269_b0155","article-title":"Understanding and overcoming CDK4\/6 inhibitor resistance in HR+\/HER2- metastatic breast cancer: clinical and molecular perspectives. Ther Adv","volume":"17","author":"da Silva","year":"2025","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0160","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1038\/s41467-023-40022-5","article-title":"Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers","volume":"14","author":"El-Botty","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2026.118269_b0165","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0170","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1078-0432.CCR-21-2947","article-title":"Mechanisms of resistance to CDK4\/6 blockade in advanced hormone receptor-positive, HER2-negative breast cancer and emerging therapeutic opportunities","volume":"28","author":"Lloyd","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.118269_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109689","article-title":"Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging","volume":"36","author":"Floerchinger","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"23","key":"10.1016\/j.bcp.2026.118269_b0185","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"issue":"5930","key":"10.1016\/j.bcp.2026.118269_b0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2026.118269_b0195","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/1541-7786.MCR-19-0856","article-title":"Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1","volume":"18","author":"Indira Chandran","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118269_b0200","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/j.2040-4603.2013.tb00533.x","article-title":"Monocarboxylic acid transport","volume":"3","author":"Halestrap","year":"2013","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0205","article-title":"COL3A1(high) cancer-associated fibroblasts orchestrate metabolic and immune microenvironments to confer chemoresistance in breast cancer","volume":"10","author":"Jiang","year":"2026","journal-title":"NPJ Precis Oncol."},{"key":"10.1016\/j.bcp.2026.118269_b0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","article-title":"Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth","volume":"25","author":"Martinez-Outschoorn","year":"2014","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118269_b0215","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-24-3173","article-title":"Cancer-associated fibroblasts foster a high-lactate microenvironment to drive perineural invasion in pancreatic cancer","volume":"85","author":"Li","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118269_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1672020","article-title":"Spatial profiling of the metabolism-immune axis in ovarian cancer","volume":"16","author":"Wang","year":"2026","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118269_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081865","article-title":"Extracellular vesicle-mediated mitochondrial reprogramming in cancer","volume":"14","author":"Carles-Fontana","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13046-024-03087-8","article-title":"Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance","volume":"43","author":"Del Vecchio","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8049","key":"10.1016\/j.bcp.2026.118269_b0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115154","article-title":"The adaptor protein Miro1 modulates horizontal transfer of mitochondria in mouse melanoma models","volume":"44","author":"Novak","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118269_b0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1479-5876-11-94","article-title":"Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance","volume":"11","author":"Pasquier","year":"2013","journal-title":"J. Transl. Med."},{"issue":"5660","key":"10.1016\/j.bcp.2026.118269_b0250","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.1093133","article-title":"Nanotubular highways for intercellular organelle transport","volume":"303","author":"Rustom","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118269_b0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00018-026-06097-1","article-title":"Building the bridges: molecular mechanisms of tunneling nanotube formation","volume":"83","author":"Brou","year":"2026","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118269_b0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41419-024-06536-6","article-title":"HMGB1 promotes mitochondrial transfer between hepatocellular carcinoma cells through RHOT1 and RAC1 under hypoxia","volume":"15","author":"Jing","year":"2024","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bcp.2026.118269_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105441","article-title":"Interaction between the mitochondrial adaptor MIRO and the motor adaptor TRAK","volume":"299","author":"Baltrusaitis","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118269_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149737","article-title":"Miro-mediated mitochondrial transport: a new dimension for disease-related abnormal cell metabolism?","volume":"705","author":"Li","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0275","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41467-023-36945-8","article-title":"TRAK adaptors regulate the recruitment and activation of dynein and kinesin in mitochondrial transport","volume":"14","author":"Canty","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s42003-025-08990-0","article-title":"Proximity labeling unveils potential roles of the Miro2-CISD1 network in mitochondrial dynamics and neuronal differentiation","volume":"9","author":"Kang","year":"2026","journal-title":"Commun. Biol."},{"issue":"23","key":"10.1016\/j.bcp.2026.118269_b0285","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","article-title":"Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy","volume":"187","author":"Baldwin","year":"2024","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2026.118269_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30081763","article-title":"Tumor microenvironment lactate: is it a cancer progression marker, immunosuppressant, and therapeutic target?","volume":"30","author":"Kim","year":"2025","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bcp.2026.118269_b0295","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s42255-022-00708-4","article-title":"Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer","volume":"4","author":"Liu","year":"2022","journal-title":"Nat Metab."},{"key":"10.1016\/j.bcp.2026.118269_b0300","article-title":"MCT1 inhibition remodels the tumor immune microenvironment for enhanced cancer immunotherapy","author":"Zhang","year":"2026","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.118269_b0305","article-title":"The role of MCT1 in tumor progression and targeted therapy: a comprehensive review","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118269_b0310","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118269_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1492050","article-title":"From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0320","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-025-00849-0","article-title":"Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies","volume":"13","author":"Xiao","year":"2025","journal-title":"Biomark Res."},{"issue":"14","key":"10.1016\/j.bcp.2026.118269_b0325","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41388-026-03733-9","article-title":"Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment","volume":"45","author":"Adams","year":"2026","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2026.118269_b0330","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118269_b0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1104771","article-title":"T-cell exhaustion and stemness in antitumor immunity: characteristics, mechanisms, and implications","volume":"14","author":"Chi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118269_b0340","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118269_b0345","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cmet.2019.10.004","article-title":"Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metabolic rewiring","volume":"30","author":"Pucino","year":"2019","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0350","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cmet.2016.10.015","article-title":"Lactate wreaks havoc on tumor-infiltrating T and NK cells","volume":"24","author":"Scott","year":"2016","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bcp.2026.118269_b0355","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.7150\/thno.105947","article-title":"Histone lactylation-driven B7-H3 expression promotes tumor immune evasion","volume":"15","author":"Ma","year":"2025","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0360","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118269_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105502","article-title":"Histone lactylation in macrophage biology and disease: from plasticity regulation to therapeutic implications","volume":"111","author":"Bao","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0370","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ccell.2019.05.015","article-title":"RAC1(P29S) induces a mesenchymal phenotypic switch via serum response factor to promote melanoma development and therapy resistance","volume":"36","author":"Lionarons","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0375","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12392","article-title":"RAC1 P29S regulates PD-L1 expression in melanoma","volume":"28","author":"Vu","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.bcp.2026.118269_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103970","article-title":"Rapamycin preserves cardiac function in autoimmune myocarditis by reprogramming Cxcl9(+) macrophages via the mTORC1-C\/EBPbeta-OSM axis","volume":"89","author":"Zhuang","year":"2026","journal-title":"Redox Biol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118269_b0385","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.7150\/thno.45219","article-title":"Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration","volume":"10","author":"Jin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118269_b0390","article-title":"Macrophage-derived chemokines in T cell regulation: implications for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118269_b0395","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160025","article-title":"mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection","volume":"133","author":"Ando","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010096","article-title":"Chemokines and chemokine receptors: orchestrating tumor metastasization","volume":"20","author":"Marcuzzi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118269_b0405","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1684\/ecn.2025.0504","article-title":"Igniting the tumor: targeting mitochondrial stress to prime breast cancer for immunotherapy","volume":"36","author":"Lin","year":"2025","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bcp.2026.118269_b0410","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0076-6879(06)06023-X","article-title":"Analysis of the spatiotemporal activation of rho GTPases using Raichu probes","volume":"406","author":"Nakamura","year":"2006","journal-title":"Methods Enzymol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118269_b0415","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","article-title":"Robust decomposition of cell type mixtures in spatial transcriptomics","volume":"40","author":"Cable","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0420","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","article-title":"Cell2location maps fine-grained cell types in spatial transcriptomics","volume":"40","author":"Kleshchevnikov","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118269_b0425","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41592-022-01480-9","article-title":"Benchmarking spatial and single-cell transcriptomics integration methods for transcript distribution prediction and cell type deconvolution","volume":"19","author":"Li","year":"2022","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0430","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41467-023-37168-7","article-title":"A comprehensive benchmarking with practical guidelines for cellular deconvolution of spatial transcriptomics","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0435","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4143\/crt.2025.033","article-title":"Spatial transcriptomic landscape of brain metastases from triple-negative breast cancer: comparison of primary tumor and brain metastases using spatial analysis","volume":"58","author":"Yoo","year":"2026","journal-title":"Cancer Res. Treat."},{"issue":"24","key":"10.1016\/j.bcp.2026.118269_b0440","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202502028","article-title":"integrating ambient ionization mass spectrometry imaging and spatial transcriptomics on the same cancer tissues to identify RNA-metabolite correlations","volume":"64","author":"Godfrey","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"9","key":"10.1016\/j.bcp.2026.118269_b0445","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1084\/jem.186.9.1487","article-title":"Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes","volume":"186","author":"Cox","year":"1997","journal-title":"J. Exp. Med."},{"issue":"25","key":"10.1016\/j.bcp.2026.118269_b0450","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1182\/blood-2010-08-299438","article-title":"Critical roles for Rac GTPases in T-cell migration to and within lymph nodes","volume":"116","author":"Faroudi","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcp.2026.118269_b0455","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/21541248.2016.1211398","article-title":"Rac1 in human diseases: the therapeutic potential of targeting Rac1 signaling regulatory mechanisms","volume":"8","author":"Marei","year":"2017","journal-title":"Small GTPases"},{"issue":"15","key":"10.1016\/j.bcp.2026.118269_b0460","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bcp.2026.118269_b0465","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood-2004-03-0781","article-title":"Rac1 is the small GTPase responsible for regulating the neutrophil chemotaxis compass","volume":"104","author":"Sun","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118269_b0470","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-25-1319","article-title":"M6 metabolite contributes to the efficacy of the Rac\/Cdc42 inhibitor MBQ-167 in metastatic breast cancer","author":"Grafals-Ruiz","year":"2026","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0475","doi-asserted-by":"crossref","first-page":"25083","DOI":"10.1038\/s41598-024-75351-y","article-title":"Novel inhibitor against Rac1 for therapeutic approach in prevention of breast cancer progression","volume":"14","author":"Singh","year":"2024","journal-title":"Sci. Rep."},{"issue":"49","key":"10.1016\/j.bcp.2026.118269_b0480","doi-asserted-by":"crossref","first-page":"33675","DOI":"10.1021\/jacs.4c11556","article-title":"Leveraging dual-ligase recruitment to enhance protein degradation via a heterotrivalent proteolysis targeting chimera","volume":"146","author":"Bond","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0485","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41467-023-44237-4","article-title":"DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance","volume":"15","author":"Schroder","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.118269_b0490","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/procel\/pwaf107","article-title":"Context matters: E3 ligase-ligand pairing strategies for optimized PROTAC performance","volume":"17","author":"Yin","year":"2025","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108532","article-title":"Functional genomics identify distinct and overlapping genes mediating resistance to different classes of heterobifunctional degraders of oncoproteins","volume":"34","author":"Shirasaki","year":"2021","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.bcp.2026.118269_b0500","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0505","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41467-021-21159-7","article-title":"Mutant-selective degradation by BRAF-targeting PROTACs","volume":"12","author":"Alabi","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118269_b0510","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118269_b0515","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-14-170","article-title":"Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.118269_b0520","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/1078-0432.CCR-23-2084","article-title":"First-line ipatasertib, atezolizumab, and taxane triplet for metastatic triple-negative breast cancer: clinical and biomarker results","volume":"30","author":"Schmid","year":"2024","journal-title":"Clin. Cancer Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:25:19Z","timestamp":1791908719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":104,"alternative-id":["S0006295226006088"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118269","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The RAC1 tripartite hub: coupling metabolic plasticity and immune evasion to dictate breast cancer cell fate","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118269"}}